Pricing Log in Create free account

Neuphoria Therapeutics Inc. (NEUP) vs Vaxxinity, Inc. (VAXX)

Neuphoria Therapeutics Inc. and Vaxxinity, Inc. are both Biotechnology companies. Neuphoria Therapeutics Inc. and Vaxxinity, Inc. are of similar size ($15.5M and $15.0M). Across the 11 metrics below, Vaxxinity, Inc. leads on 7 and Neuphoria Therapeutics Inc. on 4.

Valuation

Metric NEUP VAXX Biotechnology median
P/E n/m n/m 10.60
P/S 0.79 n/m 9.40
P/B 0.50 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.39 0.30 0.66
EV/Sales (0.42) (94.20) 9.02
Earnings yield (180.00%) 0.00% (32.88%)
Free cash flow yield (99.13%) 0.00% (23.13%)

Profitability

Metric NEUP VAXX Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (61.70%) (150.65%) (51.96%)
Return on assets (46.95%) (75.55%) (46.06%)
Return on invested capital (232.67%) 0.00% 0.00%

Growth

Metric NEUP VAXX Biotechnology median
Revenue growth (TTM) 3,535.05% — 6.76%
EPS growth (last fiscal year) (1,230.43%) 25.00% 29.88%
Revenue growth, 5-year CAGR 19.07% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric NEUP VAXX Biotechnology median
Debt to equity 0.00 0.99 0.00
Current ratio 27.85 1.89 4.97
Net debt to EBITDA 1.26 0.30 1.01

Dividend

Metric NEUP VAXX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NEUP VAXX Biotechnology median
Market cap 14.99m 15.47m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack